Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF

Eli Lilly

Market Cap: US$570.3b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Johnson & Johnson

Market Cap: US$418.6b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

AstraZeneca

Market Cap: UK£171.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Thermo Fisher Scientific

Market Cap: US$174.6b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

CSL

Market Cap: AU$128.0b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥10.2t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Zoetis

Market Cap: US$66.0b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Samsung BiologicsLtd

Market Cap: ₩72.7t

Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.6t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Haleon

Market Cap: UK£31.9b

Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Galderma Group

Market Cap: CHF 31.3b

Operates as a dermatology company worldwide.

WuXi AppTec

Market Cap: CN¥267.3b

An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.

IQVIA Holdings

Market Cap: US$30.6b

Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Sino Biopharmaceutical

Market Cap: HK$134.0b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Waters

Market Cap: US$16.6b

Provides analytical workflow solutions in Asia, the Americas, and Europe.

Incyte

Market Cap: US$15.5b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Shionogi

Market Cap: JP¥2.3t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.

WuXi Biologics (Cayman)

Market Cap: HK$120.3b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

CSPC Pharmaceutical Group

Market Cap: HK$114.8b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

Yunnan Baiyao GroupLtd

Market Cap: CN¥99.8b

Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.

Eurofins Scientific

Market Cap: €11.9b

Provides various analytical testing and laboratory services worldwide.

Medpace Holdings

Market Cap: US$12.6b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

ICON

Market Cap: US$12.4b

A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.4b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$92.2b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Orion Oyj

Market Cap: €9.3b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Qiagen

Market Cap: US$10.4b

Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.

Ipsen

Market Cap: €8.8b

Operates as a biopharmaceutical company worldwide.

Revvity

Market Cap: US$10.0b

Provides health sciences solutions, technologies, and services worldwide.

Grifols

Market Cap: €7.6b

Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.

Eisai

Market Cap: JP¥1.3t

Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.

Elanco Animal Health

Market Cap: US$8.5b

An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Caris Life Sciences

Market Cap: US$8.4b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Hangzhou Tigermed Consulting

Market Cap: CN¥55.0b

Provides contract research organization services in the People’s Republic of China and internationally.

Charles River Laboratories International

Market Cap: US$7.3b

Charles River Laboratories International, Inc.

Krka d. d

Market Cap: €6.1b

A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.